Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays

被引:66
作者
Ichiba, T
Teshima, T
Kuick, R
Misek, DE
Liu, C
Takada, Y
Maeda, Y
Reddy, P
Williams, DL
Hanash, SM
Ferrara, JLM
机构
[1] Univ Michigan, Ctr Canc, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Canc, Dept Pediat, Ann Arbor, MI 48109 USA
[3] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA
[4] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1182/blood-2002-09-2748
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The liver, skin, and gastrointestinal tract are major target organs of acute graft-versus-host disease (GVHD), the major complication of allogeneic bone marrow transplantation (BMT). In order to gain a better understanding of acute GVHD in the liver, we compared the gene expression profiles of livers after experimental allogeneic and syngeneic BMT using oilgonucleotide microarray. At 35 days after allogeneic BMT when hepatic GVHD was histologically evident, genes related to cellular effectors and acute-phase proteins were up-regulated, whereas genes largely related to metabolism and endocrine function were down-regulated. At day 7 after BMT before the development of histologic changes in the liver, interferon gamma (IFN-gamma)-inducible genes, major histocompatibility (MHC) class II molecules, and genes related to leukocyte trafficking had been up-regulated. Immunohistochemistry demonstrated that expression of IFN-gamma protein itself was increased in the spleen but not in hepatic tissue. These results suggest that the increased expression of genes associated with the attraction and activation of donor T cells induced by IFN-gamma early after BMT is important in the initiation of hepatic GVHD in this model and provide new potential molecular targets for early detection and intervention of acute GVHD. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 96 条
[1]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[2]  
ANDERSEN CB, 1993, TRANSPLANT P, V25, P1250
[3]  
BAKER KS, 1995, BONE MARROW TRANSPL, V15, P595
[4]   The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice [J].
Baker, MB ;
Altman, NH ;
Podack, ER ;
Levy, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2645-2656
[5]  
BAUGHMAN G, 1995, MOL CELL BIOL, V15, P4395
[6]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[7]   Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].
Beer, DG ;
Kardia, SLR ;
Huang, CC ;
Giordano, TJ ;
Levin, AM ;
Misek, DE ;
Lin, L ;
Chen, GA ;
Gharib, TG ;
Thomas, DG ;
Lizyness, ML ;
Kuick, R ;
Hayasaka, S ;
Taylor, JMG ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, S .
NATURE MEDICINE, 2002, 8 (08) :816-824
[8]   The role of the CC chemokine, RANTES, in acute lung allograft rejection [J].
Belperio, JA ;
Burdick, MD ;
Keane, MP ;
Xue, YY ;
Lynch, JP ;
Daugherty, BL ;
Kunkel, SL ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :461-472
[9]   Cloning of murine gp91(phox) cDNA and functional expression in a human X-linked chronic granulomatous disease cell line [J].
Bjorgvinsdottir, H ;
Zhen, L ;
Dinauer, MC .
BLOOD, 1996, 87 (05) :2005-2010
[10]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795